NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the NAPLEX with our engaging exam simulation. Our quiz-style format offers multiple-choice questions, hints, and detailed explanations to enhance your learning experience. Get ready to ace your NAPLEX exam!

Start Multiple Choice Practice Test
Start Flash Cards

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

What is the primary disease-modifying antirheumatic drug (DMARD) for sickle cell disease?

  1. Methotrexate

  2. Leflunomide

  3. Hydroxyurea

  4. Sulfasalazine

The correct answer is: Hydroxyurea

Hydroxyurea is the primary disease-modifying antirheumatic drug (DMARD) for sickle cell disease. This is because it helps to reduce the frequency of pain crises and progression of organ damage caused by sickle cell disease. Methotrexate and sulfasalazine are commonly used as DMARDs for other autoimmune conditions such as rheumatoid arthritis, but they are not effective for treating sickle cell disease. Leflunomide is also used as a DMARD for rheumatoid arthritis, but has not been proven to be effective for sickle cell disease. Therefore, hydroxyurea is the most appropriate DMARD for treating sickle cell disease.

More Questions Like This